Zhengye Biotech says no material non-public information behind unusual share trading activity

• Zhengye Biotechnology Holding issued a statement addressing unusual price and volume moves in its Nasdaq-listed Class A ordinary shares.
• No awareness of material non-public information or undisclosed developments that could explain the trading activity; operations described as continuing normally.
• Contact maintained with Nasdaq on the volume spike; cooperation planned with Nasdaq and other regulators as appropriate.
• Investors urged to use caution amid volatility; guidance to rely on SEC filings.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zhengye Biotechnology Holding Ltd. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202607210830PRIMZONEFULLFEED9765414) on July 21, 2026, and is solely responsible for the information contained therein.